Made your way to #AMIA2023? There will be an OHDSI-focused workshop today (8:30-3:30 CT) on "Igniting Data Modernization with Harmonized Standards for Cutting-Edge Health Research" in Churchill A.
8 OHDSI leaders have planned an exciting day! Hope you can join! #JoinTheJourney
Mayer and Huser develop a computerized informatics based approach to provide an overview of COVID-19 trials, studies and registries in https://t.co/qBkFHlZsSM registry.
Read the full @thePeerJ article https://t.co/yr8O11pZSr
@nlm_news #PublicHealth#Covid19#MachineLearning
The effort to comply with submission requirements is estimated to cost over $1.1 billion dollars per year; accounting for a research team’s time. Worth it? https://t.co/rbBa7NTSys @StanfordMed
@SpantranTEC I am not able to reach a representative. I have a transcript in sealed envelope. Can I forward that to you as alternative to +$60 for verification?
On Nov 8, 2018, (@EMA_News) requires that registry studies (in regulatory context) must be registered. I assume that https://t.co/y2nWO1p92H observational study registration would be regarded as equivalent to EU Electronic Register of post-authorisation studies (EU PAS Register)
#SentinelInitiative On Sensitivity: There is yet another level of sensitivity. Consider Sentinel compared to FAERS: there are events out of field of vision for Sentinel.
#AMIA2018 At our drug data analysis workshop (Sathurday): audience agrees when Olivier Bodenreider recommends:" You should not run regular expression on drug names. Consider RxNorm!"
Very nice presentations at 2018 symposium that nicely introduce new thinking about outcomes (as two subtypes (efficacy and safety)) and applying the same machinery to both #jointhejourney#ohdsi@OHDSI